Oxford University spin out Ultromics has raised £10m ($13.3m) in a series A round, led by Oxford Sciences Innovation. Ultromics has developed echocardiography analysis technology that aims to significantly increase accuracy in diagnosing coronary artery disease, reducing diagnostic errors by 75%. The technology is currently being trialled at six UK National Health Service hospitals and is to be expanded to 20 hospitals by year end. Dr Sanjiv Kaul (Head of Cardiovascular Medicine, OHSU) and Prof Michael Wooldridge (Head of Computer Science, University of Oxford). In the UK, there are more than 100 million people with heart disease who have not been diagnosed or treated for it.
Oxford University spin out Ultromics has raised £10m ($13.3m) in a series A round, led by Oxford Sciences Innovation. Ultromics has developed echocardiography analysis technology that aims to significantly increase accuracy in diagnosing coronary artery disease, reducing diagnostic errors by 75%. The technology is currently being trialled at six UK National Health Service hospitals and is to be expanded to 20 hospitals by year end. In the UK, there are more than 100 million people with heart disease who have not been diagnosed or treated for it.